NFE2L2 and nervous system disorder: Several promising PPI inhibitors have been disclosed to date that are able to enhance Nrf2 signaling with different potential therapeutic applications [74], and diaryl-azole-based compounds in particular have been demonstrated as useful agents in neurological diseases.